Key facts
- This page summarizes Robert E. Hoffman's Form 3 filing for Esperion Therapeutics, Inc. (ESPR).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 02 Apr 2025, 16:15.
Robert E. Hoffman - 01 Apr 2025 Form 3 Insider Report for Esperion Therapeutics, Inc. (ESPR)
- Reporting relationship
- Director
- Issuer ticker
- ESPR
- Reported as of
- 01 Apr 2025
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 02 Apr 2025, 16:15:48 UTC
- Prior SEC filing
- 06 Jan 2025
- Next SEC filing
- 22 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Sheldon L. Koenig, by power of attorney
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert E. Hoffman filed Form 3 for Esperion Therapeutics, Inc. (ESPR) on 02 Apr 2025.
Change
- Previous filing in this sequence was filed on 06 Jan 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Additional SEC filing notes
Filing notes and footnotes
Ownership status
The filing reports no beneficially owned securities.